These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30361061)

  • 1. The mTOR Independent Function of Tsc1 and FNIPs.
    Sager RA; Woodford MR; Mollapour M
    Trends Biochem Sci; 2018 Dec; 43(12):935-937. PubMed ID: 30361061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer.
    Backe SJ; Sager RA; Meluni KA; Woodford MR; Bourboulia D; Mollapour M
    Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
    Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Heat Shock Protein-90 in the Pathogenesis of Birt-Hogg-Dubé and Tuberous Sclerosis Complex Syndromes.
    Woodford MR; Backe SJ; Sager RA; Bourboulia D; Bratslavsky G; Mollapour M
    Urol Oncol; 2021 Jun; 39(6):322-326. PubMed ID: 32327294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The TSC1-mTOR-PLK axis regulates the homeostatic switch from Schwann cell proliferation to myelination in a stage-specific manner.
    Jiang M; Rao R; Wang J; Wang J; Xu L; Wu LM; Chan JR; Wang H; Lu QR
    Glia; 2018 Sep; 66(9):1947-1959. PubMed ID: 29722913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Guijarro MV; Danielson LS; Cañamero M; Nawab A; Abrahan C; Hernando E; Palmer GD
    Cells; 2020 Sep; 9(9):. PubMed ID: 32927859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking tuberous sclerosis complex, excessive mTOR signaling, and age-related neurodegeneration: a new association between TSC1 mutation and frontotemporal dementia.
    Olney NT; Alquezar C; Ramos EM; Nana AL; Fong JC; Karydas AM; Taylor JB; Stephens ML; Argouarch AR; Van Berlo VA; Dokuru DR; Sherr EH; Jicha GA; Dillon WP; Desikan RS; De May M; Seeley WW; Coppola G; Miller BL; Kao AW
    Acta Neuropathol; 2017 Nov; 134(5):813-816. PubMed ID: 28828560
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-Aza-2'-deoxycytidine increases hypoxia tolerance-dependent autophagy in mouse neuronal cells by initiating the TSC1/mTOR pathway.
    Qi R; Zhang X; Xie Y; Jiang S; Liu Y; Liu X; Xie W; Jia X; Bade R; Shi R; Li S; Ren C; Gong K; Zhang C; Shao G
    Biomed Pharmacother; 2019 Oct; 118():109219. PubMed ID: 31325707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberous sclerosis: from tubers to mTOR.
    Kwiatkowski DJ
    Ann Hum Genet; 2003 Jan; 67(Pt 1):87-96. PubMed ID: 12556239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation.
    Centini R; Tsang M; Iwata T; Park H; Delrow J; Margineantu D; Iritani BM; Gu H; Liggitt HD; Kang J; Kang L; Hockenbery DM; Raftery D; Iritani BM
    PLoS One; 2018; 13(6):e0197973. PubMed ID: 29897930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSC1/mTOR-controlled metabolic-epigenetic cross talk underpins DC control of CD8+ T-cell homeostasis.
    Shi L; Chen X; Zang A; Li T; Hu Y; Ma S; Lü M; Yin H; Wang H; Zhang X; Zhang B; Leng Q; Yang J; Xiao H
    PLoS Biol; 2019 Aug; 17(8):e3000420. PubMed ID: 31433805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent.
    Jaeschke A; Hartkamp J; Saitoh M; Roworth W; Nobukuni T; Hodges A; Sampson J; Thomas G; Lamb R
    J Cell Biol; 2002 Oct; 159(2):217-24. PubMed ID: 12403809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic renal angiomyolipoma in a patient with Birt-Hogg-Dubé: chaperones in pathogenesis.
    Sager RA; Woodford MR; Shapiro O; Mollapour M; Bratslavsky G
    Oncotarget; 2018 Apr; 9(31):22220-22229. PubMed ID: 29774133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tackling Tsc1 to Promote Nephrogenesis.
    Ingelfinger JR
    N Engl J Med; 2018 Dec; 379(25):2476-2478. PubMed ID: 30575479
    [No Abstract]   [Full Text] [Related]  

  • 16. Methylation of Hypothalamic Tsc1-mTOR Signaling in Regulation of Obesity and Obesity Resistance.
    Wang Y; Diao S; Hu M; Zhang L
    Biomed Res Int; 2020; 2020():8723869. PubMed ID: 33532487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex.
    Alves MM; Fuhler GM; Queiroz KC; Scholma J; Goorden S; Anink J; Spek CA; Hoogeveen-Westerveld M; Bruno MJ; Nellist M; Elgersma Y; Aronica E; Peppelenbosch MP
    Sci Rep; 2015 Sep; 5():14534. PubMed ID: 26412398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
    Curatolo P
    Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.
    Chan JA; Zhang H; Roberts PS; Jozwiak S; Wieslawa G; Lewin-Kowalik J; Kotulska K; Kwiatkowski DJ
    J Neuropathol Exp Neurol; 2004 Dec; 63(12):1236-42. PubMed ID: 15624760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model.
    Polchi A; Magini A; Meo DD; Tancini B; Emiliani C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.